{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:20:10Z","timestamp":1778368810385,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the General Project of Inner Mongolia Natural Science Foundation","award":["No. 2022MS08063"],"award-info":[{"award-number":["No. 2022MS08063"]}]},{"name":"the Key Research and Development and Achievement Transformation Project in the Social Welfare Field of the 14th Five-Year Plan in the Inner Mongolia Autonomous Region","award":["No. 2022YFSH0087"],"award-info":[{"award-number":["No. 2022YFSH0087"]}]},{"name":"the Inner Mongolia Health Science and Technology Project in 2022","award":["No. 202201293"],"award-info":[{"award-number":["No. 202201293"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81960143"],"award-info":[{"award-number":["No. 81960143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Inner Mongolia Grassland Talents Program Young Innovative Talent Project","award":["No. Q2022082"],"award-info":[{"award-number":["No. Q2022082"]}]},{"name":"the Shanghai Key Laboratory of Kidney and Blood Purification","award":["No. 14DZ226022"],"award-info":[{"award-number":["No. 14DZ226022"]}]},{"name":"Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences","award":["No. 2024GLLH0337"],"award-info":[{"award-number":["No. 2024GLLH0337"]}]},{"name":"the Trinity College Students Innovation and Entrepreneurship Cultivation Project of Inner Mongolia Medical University","award":["No. SWYT2020008"],"award-info":[{"award-number":["No. SWYT2020008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37486-y","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:55:41Z","timestamp":1769529341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nuclear receptor corepressor 1 is a potential diagnostic and prognostic biomarker in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Lu-ri","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu-niri","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-cheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"1","key":"37486_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21873\/invivo.13049","volume":"37","author":"S Grammatikaki","year":"2023","unstructured":"Grammatikaki, S. et al. An overview of epigenetics in clear cell renal cell carcinoma. Vivo 37 (1), 1\u201310 (2023).","journal-title":"Vivo"},{"issue":"2","key":"37486_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11934-017-0661-3","volume":"18","author":"JM Speed","year":"2017","unstructured":"Speed, J. M., Trinh, Q. D., Choueiri, T. K. & Sun, M. Recurrence in localized renal cell carcinoma: a systematic review of contemporary data. Curr. Urol. Rep. 18 (2), 15 (2017).","journal-title":"Curr. Urol. Rep."},{"issue":"6","key":"37486_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/JLB.1RI0418-168R","volume":"104","author":"L M\u00fcller","year":"2018","unstructured":"M\u00fcller, L., Hainberger, D., Stolz, V. & Ellmeier, W. NCOR1-a new player on the field of T cell development. J. Leukoc. Biol. 104 (6), 1061\u20131068 (2018).","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"37486_CR4","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1038\/s41467-024-49692-1","volume":"15","author":"R Culliford","year":"2024","unstructured":"Culliford, R. et al. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Nat. Commun. 15 (1), 5935 (2024).","journal-title":"Nat. Commun."},{"issue":"6","key":"37486_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/cbin.10973","volume":"42","author":"TI Lima","year":"2018","unstructured":"Lima, T. I. et al. Role of NCoR1 in mitochondrial function and energy metabolism. Cell. Biol. Int. 42 (6), 734\u2013741 (2018).","journal-title":"Cell. Biol. Int."},{"key":"37486_CR6","doi-asserted-by":"crossref","unstructured":"Meng, X. et al. Thyroid hormone receptor \u03b21 and PGC1\u03b1 coordinately regulate OPA1\/MFN2-Mediated mitochondrial fusion and UCP1-Mediated lipid Browning in CcRCC. Adv. Sci. (Weinh). e08571 (2025). Epub ahead of print.","DOI":"10.1002\/advs.202508571"},{"key":"37486_CR7","unstructured":"Daojia, M. et al. Targeting MMA-induced USP36 methylmalonylation to suppress macrophage polarization and tumor progression in clear-cell renal cell carcinoma. Cell. Death Differ. (2025). Epub ahead of print."},{"issue":"1","key":"37486_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41420-025-02479-9","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Zhang, S., Sun, H. & Xu, L. The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma. Cell. Death Discov. 11 (1), 186 (2025).","journal-title":"Cell. Death Discov"},{"issue":"8","key":"37486_CR9","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1073\/pnas.0803507106","volume":"106","author":"M Dobrzynski","year":"2009","unstructured":"Dobrzynski, M. & Bruggeman, F. J. Elongation dynamics shape bursty transcription and translation. Proc. Natl. Acad. Sci. U S A. 106 (8), 2583\u20132588 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"37486_CR10","doi-asserted-by":"publisher","first-page":"E328","DOI":"10.1073\/pnas.1520469113","volume":"113","author":"OA Mart\u00ednez-Iglesias","year":"2016","unstructured":"Mart\u00ednez-Iglesias, O. A. et al. Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis. Proc. Natl. Acad. Sci. U S A. 113 (3), E328\u2013E337 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"12","key":"37486_CR11","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1002\/2211-5463.13004","volume":"10","author":"L Tang","year":"2020","unstructured":"Tang, L. et al. NCOR1 May be a potential biomarker of a novel molecular subtype of prostate cancer. FEBS Open. Bio. 10 (12), 2678\u20132686 (2020).","journal-title":"FEBS Open. Bio"},{"issue":"12","key":"37486_CR12","doi-asserted-by":"publisher","first-page":"BSR20192362","DOI":"10.1042\/BSR20192362","volume":"39","author":"J Tan","year":"2019","unstructured":"Tan, J. et al. Abnormally localized DLK1 interacts with NCOR1 in non-small cell lung cancer cell nuclear. Biosci. Rep. 39 (12), BSR20192362 (2019).","journal-title":"Biosci. Rep."},{"issue":"2","key":"37486_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13402-015-0258-0","volume":"39","author":"W Wang","year":"2016","unstructured":"Wang, W., Song, X. W., Bu, X. M., Zhang, N. & Zhao, C. H. PDCD2 and NCoR1 as putative tumor suppressors in gastric Gastrointestinal stromal tumors. Cell. Oncol. (Dordr). 39 (2), 129\u2013137 (2016).","journal-title":"Cell. Oncol. (Dordr)"},{"key":"37486_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.omtn.2021.11.026","volume":"27","author":"Y Qiu","year":"2022","unstructured":"Qiu, Y. et al. RNA-binding protein MEX3A controls G1\/S transition via regulating the RB\/E2F pathway in clear cell renal cell carcinoma. Mol. Ther. Nucleic Acids. 27, 241\u2013255 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"37486_CR15","doi-asserted-by":"publisher","first-page":"1617968","DOI":"10.3389\/fimmu.2025.1617968","volume":"16","author":"M Wang","year":"2025","unstructured":"Wang, M. et al. Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities. Front. Immunol. 16, 1617968 (2025).","journal-title":"Front. Immunol."},{"issue":"5","key":"37486_CR16","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s11357-023-00849-8","volume":"45","author":"AM Elmansi","year":"2023","unstructured":"Elmansi, A. M. & Miller, R. A. Coordinated transcriptional upregulation of oxidative metabolism proteins in long-lived endocrine mutant mice. Geroscience 45 (5), 2967\u20132981 (2023).","journal-title":"Geroscience"},{"issue":"12","key":"37486_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15 (12), 550 (2014).","journal-title":"Genome Biol."},{"key":"37486_CR18","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.2147\/IJGM.S367173","volume":"15","author":"Y Luo","year":"2022","unstructured":"Luo, Y. & Zhang, G. Identification of a Necroptosis-Related prognostic index and associated regulatory axis in kidney renal clear cell carcinoma. Int. J. Gen. Med. 15, 5407\u20135423 (2022).","journal-title":"Int. J. Gen. Med."},{"issue":"43","key":"37486_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"D1","key":"37486_CR20","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"37486_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"37486_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"37486_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16 (5), 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"37486_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"issue":"4","key":"37486_CR25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39 (4), 782\u2013795 (2013).","journal-title":"Immunity"},{"issue":"8","key":"37486_CR26","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry, K. C. et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat. Med. 24 (8), 1178\u20131191 (2018).","journal-title":"Nat. Med."},{"issue":"1","key":"37486_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10120-019-00983-3","volume":"23","author":"S Pernot","year":"2020","unstructured":"Pernot, S. et al. Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance. Gastric Cancer. 23 (1), 73\u201381 (2020).","journal-title":"Gastric Cancer"},{"issue":"6","key":"37486_CR28","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","volume":"183","author":"MF Krummel","year":"1996","unstructured":"Krummel, M. F. & Allison, J. P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183 (6), 2533\u20132540 (1996).","journal-title":"J. Exp. Med."},{"issue":"1","key":"37486_CR29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.18632\/oncotarget.13483","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang, X. & Sun, Q. TP53 mutations, expression and interaction networks in human cancers. Oncotarget 8 (1), 624\u2013643 (2017).","journal-title":"Oncotarget"},{"issue":"3","key":"37486_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2014.03.027","volume":"157","author":"A Papa","year":"2014","unstructured":"Papa, A. et al. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 157 (3), 595\u2013610 (2014).","journal-title":"Cell"},{"issue":"3","key":"37486_CR31","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"37486_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3109\/09553002.2014.892229","volume":"90","author":"K M\u00e4bert","year":"2014","unstructured":"M\u00e4bert, K. et al. Cancer biomarker discovery: current status and future perspectives. Int. J. Radiat. Biol. 90 (8), 659\u2013677 (2014).","journal-title":"Int. J. Radiat. Biol."},{"issue":"8","key":"37486_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/biom12081021","volume":"12","author":"VK Sarhadi","year":"2022","unstructured":"Sarhadi, V. K. & Armengol, G. Molecular biomarkers in cancer. Biomolecules 12 (8), 1021 (2022).","journal-title":"Biomolecules"},{"issue":"1","key":"37486_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/BJ20120751","volume":"447","author":"M Ji","year":"2012","unstructured":"Ji, M. et al. Phospho-regulation of KIBRA by CDK1 and CDC14 phosphatase controls cell-cycle progression. Biochem. J. 447 (1), 93\u2013102 (2012).","journal-title":"Biochem. J."},{"issue":"Pt 20","key":"37486_CR35","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1242\/jcs.00754","volume":"116","author":"S Willis","year":"2003","unstructured":"Willis, S., Day, C. L., Hinds, M. G. & Huang, D. C. The Bcl-2-regulated apoptotic pathway. J. Cell. Sci. 116 (Pt 20), 4053\u20134056 (2003).","journal-title":"J. Cell. Sci."},{"issue":"2","key":"37486_CR36","first-page":"455","volume":"59","author":"CS Melincovici","year":"2018","unstructured":"Melincovici, C. S. et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J. Morphol. Embryol. 59 (2), 455\u2013467 (2018).","journal-title":"Rom J. Morphol. Embryol."},{"issue":"601","key":"37486_CR37","doi-asserted-by":"publisher","first-page":"eaay0482","DOI":"10.1126\/scisignal.aay0482","volume":"12","author":"HE Nicholson","year":"2019","unstructured":"Nicholson, H. E. et al. HIF-independent synthetic lethality between CDK4\/6 Inhibition and VHL loss across species. Sci. Signal. 12 (601), eaay0482 (2019).","journal-title":"Sci. Signal."},{"issue":"4","key":"37486_CR38","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/bcr1533","volume":"8","author":"M Shapira","year":"2006","unstructured":"Shapira, M., Kakiashvili, E., Rosenberg, T. & Hershko, D. D. The mTOR inhibitor Rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells. Breast Cancer Res. 8 (4), R46 (2006).","journal-title":"Breast Cancer Res."},{"issue":"1","key":"37486_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P. & Ostrand-Rosenberg, S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 70 (1), 68\u201377 (2010).","journal-title":"Cancer Res."},{"issue":"12","key":"37486_CR40","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1172\/JCI77053","volume":"124","author":"EB Eruslanov","year":"2014","unstructured":"Eruslanov, E. B. et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest. 124 (12), 5466\u20135480 (2014).","journal-title":"J. Clin. Invest."},{"issue":"6","key":"37486_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41419-023-05879-w","volume":"14","author":"H Ren","year":"2023","unstructured":"Ren, H. et al. FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury. Cell. Death Dis. 14 (6), 367 (2023).","journal-title":"Cell. Death Dis."},{"issue":"9","key":"37486_CR42","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/eji.202048794","volume":"51","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Transcriptional and posttranslational regulation of Th17\/Treg balance in health and disease. Eur. J. Immunol. 51 (9), 2137\u20132150 (2021).","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"37486_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12935-021-01834-x","volume":"21","author":"S Liu","year":"2021","unstructured":"Liu, S., Wang, Y., Miao, C., Xing, Q. & Wang, Z. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity. Cancer Cell. Int. 21 (1), 140 (2021).","journal-title":"Cancer Cell. Int."},{"issue":"44","key":"37486_CR44","doi-asserted-by":"publisher","first-page":"e10501","DOI":"10.1002\/advs.202510501","volume":"12","author":"Z Yu","year":"2025","unstructured":"Yu, Z. et al. CDK4\/6 inhibitor priming enhances PD-1 Blockade via Sellhi Neutrophil-Induced Stat5a+ progenitor exhausted CD8\u2009+\u2009T cell. Adv. Sci. (Weinh). 12 (44), e10501 (2025).","journal-title":"Adv. Sci. (Weinh)"},{"key":"37486_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/bs.apcsb.2022.11.009","volume":"135","author":"A Rezaeian","year":"2023","unstructured":"Rezaeian, A., Inuzuka, H. & Wei, W. Insights into the aberrant CDK4\/6 signaling pathway as a therapeutic target in tumorigenesis. Adv. Protein Chem. Struct. Biol. 135, 179\u2013201 (2023).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"13","key":"37486_CR46","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.7150\/ijbs.74647","volume":"18","author":"W Xu","year":"2022","unstructured":"Xu, W. et al. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma. Int. J. Biol. Sci. 18 (13), 4884\u20134900 (2022).","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"37486_CR47","doi-asserted-by":"publisher","first-page":"e006170","DOI":"10.1136\/jitc-2022-006170","volume":"11","author":"N Shakfa","year":"2023","unstructured":"Shakfa, N. et al. Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer. J. Immunother Cancer.  11(4), e006170 (2023).","journal-title":"J. Immunother Cancer."},{"issue":"7","key":"37486_CR48","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.immuni.2025.06.005","volume":"58","author":"DB Mahat","year":"2025","unstructured":"Mahat, D. B. et al. Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. Immunity 58 (7), 1688\u20131705e9 (2025).","journal-title":"Immunity"},{"issue":"10","key":"37486_CR49","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.immuni.2024.08.015","volume":"57","author":"Z Nian","year":"2024","unstructured":"Nian, Z. et al. Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation. Immunity 57 (10), 2344\u20132361e7 (2024).","journal-title":"Immunity"},{"issue":"8","key":"37486_CR50","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl. J. Med. 363 (8), 711\u2013723 (2010).","journal-title":"N Engl. J. Med."},{"issue":"11","key":"37486_CR51","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jamaoncol.2017.1588","volume":"3","author":"GV Long","year":"2017","unstructured":"Long, G. V. et al. Nivolumab for patients with advanced melanoma treated beyond progression: analysis of 2 phase 3 clinical trials. JAMA Oncol. 3 (11), 1511\u20131519 (2017).","journal-title":"JAMA Oncol."},{"issue":"8","key":"37486_CR52","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/14712598.2018.1499722","volume":"18","author":"O Waidmann","year":"2018","unstructured":"Waidmann, O. Recent developments with immunotherapy for hepatocellular carcinoma. Expert Opin. Biol. Ther. 18 (8), 905\u2013910 (2018).","journal-title":"Expert Opin. Biol. Ther."},{"key":"37486_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ebiom.2018.05.019","volume":"32","author":"W Xiao","year":"2018","unstructured":"Xiao, W. et al. TP53 mutation as potential negative predictor for response of Anti-CTLA-4 therapy in metastatic Melanoma. EBioMedicine. 32, 119\u2013124 (2018).","journal-title":"EBioMedicine"},{"key":"37486_CR54","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.csbj.2019.07.009","volume":"17","author":"H Lyu","year":"2019","unstructured":"Lyu, H., Li, M., Jiang, Z., Liu, Z. & Wang, X. Correlate the TP53 mutation and the HRAS mutation with immune signatures in head and neck squamous cell cancer. Comput. Struct. Biotechnol. J. 17, 1020\u20131030 (2019).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"4","key":"37486_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","volume":"18","author":"DA Braun","year":"2021","unstructured":"Braun, D. A. et al. Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. Nat. Rev. Clin. Oncol. 18 (4), 199\u2013214 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"37486_CR56","doi-asserted-by":"publisher","first-page":"e071534","DOI":"10.1136\/bmjopen-2022-071534","volume":"13","author":"SJ Bowden","year":"2023","unstructured":"Bowden, S. J. et al. Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management. BMJ Open. 13 (6), e071534 (2023).","journal-title":"BMJ Open."},{"issue":"2","key":"37486_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s13277-011-0282-2","volume":"33","author":"TA Rauch","year":"2012","unstructured":"Rauch, T. A. et al. DNA methylation biomarkers for lung cancer. Tumour Biol. 33 (2), 287\u2013296 (2012).","journal-title":"Tumour Biol."},{"issue":"7","key":"37486_CR58","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/leu.2011.44","volume":"25","author":"MJ Walter","year":"2011","unstructured":"Walter, M. J. et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 25 (7), 1153\u20131158 (2011).","journal-title":"Leukemia"},{"issue":"12","key":"37486_CR59","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1158\/0008-5472.CAN-21-4349","volume":"82","author":"M An","year":"2022","unstructured":"An, M. et al. Aberrant nuclear export of circNCOR1 underlies SMAD7-Mediated lymph node metastasis of bladder cancer. Cancer Res. 82 (12), 2239\u20132253 (2022).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37486-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:05:47Z","timestamp":1770980747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37486-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37486"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37486-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8086725\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Inner Mongolia Medical University (No. YKD202403009). The patients\/participants provided written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"6303"}}